Search





Search





Markets
/
Stocks
/
cmpx
/

Compass Therapeutics Inc.

CMPX

Add to Watchlist

1.910USD

-0.030-1.55%

Close 07-31 16:00（ET）Quotes delayed by 15 min

343.97MMarket Cap

LossP/E TTM

Compass Therapeutics Inc.

1.910

-0.030-1.55%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

CMPX Cash Flow Statement

You can access the annual and quarterly cash flow statements of Compass Therapeutics Inc. to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2019Q4

FY2019Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-30.75%-17.27M

-44.66%-13.25M

1.83%-10.85M

-10.02%-11.83M

4.90%-13.21M

25.84%-9.16M

-86.61%-11.05M

-6.34%-10.75M

-13.57%-13.89M

-16.10%-12.35M

45.88%-5.92M

-119.85%-10.11M

-53.98%-12.23M

-128.10%-10.64M

-216.52%-10.94M

22.55%-4.60M

-41.69%-7.94M

29.03%-4.67M

51.78%-3.46M

---5.94M

---5.61M

-17.56%-6.57M

-6.94%-7.17M

---5.59M

---6.70M

Net income from continuing operations

-10.12%-18.32M

-4.54%-15.72M

-36.07%-14.26M

-52.04%-19.88M

-54.19%-16.63M

-12.06%-15.03M

-5.17%-10.48M

-15.94%-13.08M

-37.64%-10.79M

-15.71%-13.41M

16.79%-9.96M

-32.78%-11.28M

-9.42%-7.84M

10.68%-11.59M

-100.35%-11.97M

84.78%-8.49M

3.50%-7.16M

-54.70%-12.98M

34.68%-5.98M

---55.80M

---7.42M

-26.91%-8.39M

-6.99%-9.15M

---6.61M

---8.55M

Operating gains losses

1.10%368.00K

164.29%370.00K

159.44%371.00K

141.45%367.00K

136.36%364.00K

-13.04%140.00K

-12.80%143.00K

-15.56%152.00K

-20.62%154.00K

-17.44%161.00K

-18.81%164.00K

-18.18%180.00K

17.58%194.00K

57.26%195.00K

46.38%202.00K

49.66%220.00K

5.10%165.00K

-88.40%124.00K

-68.28%138.00K

--147.00K

--157.00K

105.18%1.07M

-19.29%435.00K

--521.00K

--539.00K

Other non-cash items

-892.31%-206.00K

-2245.10%-1.20M

-952.27%-375.00K

69.01%-128.00K

138.81%26.00K

89.90%-51.00K

109.09%44.00K

44.19%-413.00K

78.10%-67.00K

-56.83%-505.00K

-3126.67%-484.00K

-290.72%-740.00K

-213.33%-306.00K

-218.38%-322.00K

-105.60%-15.00K

-99.24%388.00K

5.47%270.00K

--272.00K

--268.00K

--50.88M

--256.00K

----

Change in working capital

-903.65%-4.19M

-58.72%1.46M

173.59%2.18M

986.36%5.02M

110.04%521.00K

1917.44%3.54M

-208.04%-2.96M

376.29%462.00K

6.42%-5.19M

-454.55%-195.00K

720.63%2.74M

-94.93%97.00K

-98.89%-5.55M

-99.18%55.00K

-138.52%-441.00K

191.92%1.91M

-675.05%-2.79M

1230.91%6.70M

213.14%1.15M

---2.08M

--485.00K

-343.62%-592.00K

-199.51%-1.01M

--243.00K

--1.02M

-Change in prepaid expenses

98.41%-87.00K

157.88%312.00K

154.33%4.02M

226.21%6.26M

-485.58%-5.48M

-136.89%-539.00K

-56.55%1.58M

-359.57%-4.96M

-274.40%-936.00K

123.45%1.46M

532.87%3.64M

38.85%1.91M

80.96%-250.00K

-1422.72%-6.23M

118.63%575.00K

200.29%1.38M

-211.94%-1.31M

158.00%471.00K

166.25%263.00K

---1.37M

--1.17M

-492.27%-812.00K

-171.40%-397.00K

--207.00K

--556.00K

-Change in other current assets

----

100.00%0.00

----

-950.00%-315.00K

-112.50%-7.00K

---30.00K

--56.00K

-Change in other current liabilities

----

--0.00

----

100.00%0.00

--0.00

---44.00K

--0.00

Cash from non-recurring investing activities

Cash from operating activities

-30.75%-17.27M

-44.66%-13.25M

1.83%-10.85M

-10.02%-11.83M

4.90%-13.21M

25.84%-9.16M

-86.61%-11.05M

-6.34%-10.75M

-13.57%-13.89M

-16.10%-12.35M

45.88%-5.92M

-119.85%-10.11M

-53.98%-12.23M

-128.10%-10.64M

-216.52%-10.94M

22.55%-4.60M

-41.69%-7.94M

29.03%-4.67M

51.78%-3.46M

---5.94M

---5.61M

-17.56%-6.57M

-6.94%-7.17M

---5.59M

---6.70M

Investing cash flow

Net cash from continuing investing activities

355.56%82.00K

--0.00

-84.09%7.00K

--0.00

--18.00K

-100.00%0.00

340.00%44.00K

----

-83.33%9.00K

-62.96%10.00K

104.62%11.00K

-100.00%0.00

-93.04%54.00K

-92.64%27.00K

-138.76%-238.00K

1384.62%193.00K

13033.33%776.00K

5142.86%367.00K

--614.00K

--13.00K

-103.24%-6.00K

-74.07%7.00K

--185.00K

--27.00K

Capital expenditures

355.56%82.00K

--0.00

-84.09%7.00K

--0.00

--18.00K

-100.00%0.00

340.00%44.00K

----

-83.33%9.00K

-62.96%10.00K

--11.00K

-100.00%0.00

-93.05%54.00K

-92.64%27.00K

----

51.56%194.00K

836.14%777.00K

5142.86%367.00K

--614.00K

--128.00K

-55.14%83.00K

-74.07%7.00K

--185.00K

--27.00K

Net cash flow from disposal of fixed assets

355.56%82.00K

--0.00

-84.09%7.00K

--0.00

--18.00K

-100.00%0.00

340.00%44.00K

----

-83.33%9.00K

-62.96%10.00K

104.62%11.00K

-100.00%0.00

-93.04%54.00K

-92.64%27.00K

-138.76%-238.00K

1384.62%193.00K

13033.33%776.00K

5142.86%367.00K

--614.00K

--13.00K

-103.24%-6.00K

-74.07%7.00K

--185.00K

--27.00K

Net cash flow from investment products

231.82%38.51M

-121.98%-3.38M

-427.40%-95.15M

-198.10%-6.36M

383.14%11.61M

143.08%15.37M

70.36%29.06M

1088.26%6.48M

-196.02%-4.10M

113.57%6.32M

1313.34%17.06M

99.38%-656.00K

--4.27M

---46.59M

--1.21M

---105.78M

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

231.63%38.43M

-121.98%-3.38M

-427.92%-95.16M

-198.10%-6.36M

382.70%11.59M

143.43%15.37M

70.20%29.02M

1071.96%6.48M

-196.02%-4.10M

113.54%6.31M

1344.83%17.05M

99.37%-667.00K

2311.92%4.27M

-5911.08%-46.65M

421.53%1.18M

-17089.09%-105.54M

-1384.62%-193.00K

-13033.33%-776.00K

-5142.86%-367.00K

---614.00K

---13.00K

103.24%6.00K

74.07%-7.00K

---185.00K

---27.00K

Financing cash flow

Cash flow from continuous financing activities

512.88%3.37M

1230.85%1.06M

6468150.00%129.36M

-100.00%0.00

-104.68%-815.00K

40.51%-94.00K

-109.52%-2.00K

-99.97%1.00K

42419.51%17.43M

-100.21%-158.00K

320.00%21.00K

--3.03M

--41.00K

-39.03%75.75M

100.27%5.00K

100.00%0.00

6725.92%124.24M

29.96%-1.88M

---1.88M

---2.68M

--0.00

Net cash flow from debt Issuance/repayment

----

100.00%0.00

-100.00%-3.75M

0.00%-1.88M

---1.88M

--0.00

Net cash flow from preferred stock issuance/repurchase

----

--0.00

----

Proceeds from stock option exercised by employees

--3.85M

--1.27M

--138.00M

--0.00

-100.00%0.00

--0.00

-100.00%0.00

44078.05%18.11M

-100.00%0.00

320.00%21.00K

--3.13M

--41.00K

-40.56%76.25M

--5.00K

----

--128.27M

--0.00

----

--0.00

Net cash flow from other financing activities

40.00%-489.00K

-125.53%-212.00K

-431800.00%-8.64M

-100.00%0.00

-19.85%-815.00K

40.51%-94.00K

---2.00K

101.05%1.00K

---680.00K

68.08%-158.00K

--0.00

---95.00K

----

-76.16%-495.00K

----

---281.00K

100.00%0.00

----

--0.00

---802.00K

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

512.88%3.37M

1230.85%1.06M

6468150.00%129.36M

-100.00%0.00

-104.68%-815.00K

40.51%-94.00K

-109.52%-2.00K

-99.97%1.00K

42419.51%17.43M

-100.21%-158.00K

320.00%21.00K

--3.03M

--41.00K

-39.03%75.75M

100.27%5.00K

100.00%0.00

6725.92%124.24M

29.96%-1.88M

---1.88M

---2.68M

--0.00

Net cash flow

Beginning cash balance

-29.15%31.21M

25.18%46.78M

20.72%23.42M

75.79%41.62M

81.82%44.05M

22.82%37.37M

0.65%19.40M

-12.41%23.67M

-30.67%24.23M

84.61%30.43M

-26.53%19.28M

-80.18%27.03M

-75.82%34.95M

-35.92%16.48M

-16.49%26.24M

242.27%136.38M

205.27%144.51M

-53.89%25.72M

-52.13%31.42M

--39.85M

--47.34M

77.98%55.78M

72.39%65.63M

--31.34M

--38.07M

Current period cash flow changes

1107.19%24.52M

-354.65%-15.57M

30.01%23.36M

-326.04%-18.19M

-339.53%-2.44M

198.64%6.11M

61.15%17.96M

44.90%-4.27M

93.00%-554.00K

-133.57%-6.20M

214.26%11.15M

92.96%-7.75M

2.66%-7.92M

-84.46%18.46M

-71.21%-9.76M

-1206.85%-110.14M

-8.57%-8.13M

1507.19%118.80M

42.16%-5.70M

---8.43M

---7.49M

-46.16%-8.44M

-46.38%-9.85M

---5.78M

---6.73M

Ending cash balance

33.93%55.74M

-28.22%31.21M

25.18%46.78M

20.72%23.42M

75.79%41.62M

79.47%43.48M

22.82%37.37M

0.65%19.40M

-12.41%23.67M

-30.67%24.23M

84.61%30.43M

-26.53%19.28M

-80.18%27.03M

-75.82%34.95M

-35.92%16.48M

-16.49%26.24M

242.27%136.38M

205.27%144.51M

-53.89%25.72M

--31.42M

--39.85M

85.16%47.34M

77.98%55.78M

--25.57M

--31.34M

Free cash flow

-31.19%-17.35M

-44.66%-13.25M

2.15%-10.86M

-10.02%-11.83M

4.77%-13.23M

25.89%-9.16M

-87.04%-11.10M

-6.22%-10.75M

-13.57%-13.89M

-15.60%-12.36M

45.92%-5.93M

-120.09%-10.12M

-50.31%-12.23M

-96.53%-10.70M

-186.85%-10.97M

29.80%-4.60M

-41.92%-8.14M

18.24%-5.44M

46.71%-3.82M

---6.55M

---5.73M

-15.24%-6.66M

-6.61%-7.18M

---5.78M

---6.73M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Compass Therapeutics Inc. Generate?



Compass Therapeutics Inc. generated -49.14M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Compass Therapeutics Inc.'s Operating Cash Flow Change Year Over Year?



Compass Therapeutics Inc.'s operating cash flow increased by -9.56% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Compass Therapeutics Inc. Spend on Capital Expenditures?



Compass Therapeutics Inc. spent 25.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Compass Therapeutics Inc.'s Financing Cash Flow Changed?



Compass Therapeutics Inc. used 129.61M in financing activities in the latest quarter.

What is free cash flow and why does it matter for CMPX?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Compass Therapeutics Inc.’s free cash flow in the latest quarter?



Free cash flow was -49.17M reflecting a -9.51% change from the previous year.